PUBLISHER: Market Research Future | PRODUCT CODE: 1339045

PUBLISHER: Market Research Future | PRODUCT CODE: 1339045

GCC Clinical Reference Laboratory Market Research Report Forecast to 2030

PUBLISHED: August 17, 2023

PAGES: 63 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The growth of the Gulf Cooperation Council (GCC) clinical reference laboratory market is attributed to the growing prevalence of chronic disorders, increased burden of target diseases, and increasing outsourcing from hospitals. However, stringent regulatory frameworks and high costs of advanced technologies are anticipated to hamper market growth.

Clinical reference laboratories are used to support, diagnose, analysis patient care as well as used for medical research. Laboratory services are an essential part of disease diagnosis, treatment, monitoring response to treatment, disease surveillance programs, and clinical research. The clinical reference laboratory market growth witnessed a significant rise due to the accelerating demand for clinical trials owing to the growing chronic ailments among the expanding populace. Such laboratories are predicted to acquire prominence in the forecast term due to the reduced hospital budget and declining Medicare reimbursements. In addition, the increasing value-based outsourcing from hospitals is likely to augment the clinical laboratory services market share during the forecast period.

The expected growth in the market can be attributed to the growing prevalence of chronic disorders and the increased burden of target diseases. However, the market is also held back by stringent regulatory frameworks and the high costs of advanced technologies. Nevertheless, it is anticipated that the increasing outsourcing from hospitals will create lucrative opportunities for the players operating in the GCC clinical reference laboratory market.

Market Segmentation

Based on service, the Gulf Cooperation Council (GCC) clinical reference laboratory market is segmented into stand alone, hospital based, and clinic based.

Based on application, the Gulf Cooperation Council (GCC) clinical reference laboratory market has been segmented into clinical trials and laboratory medicine.

Regional Analysis

Increasing value-based outsourcing from hospitals, application of advanced automation technology in reference laboratories, and cost and time savings for hospitals and clinics due to the increase in outsourcing by independent laboratories are the key driving factors for the Gulf Cooperation Council (GCC) clinical reference laboratory market. Clinical reference laboratories have gained immense importance during the COVID-19 pandemic owing to the increasing demand for testing. Key players are focusing on collaborations for providing new lab testing services. For instance, in March 2022, GC Labs entered into a service agreement with Bio Lab in Bahrain and Biotrust in Cambodia, expanding its presence in Asia & Middle East.

Major Players

Quest Diagnostics (US), SRL Diagnostics (India), Unilabs (Switzerland), Pure Lab (UAE), Thumbay Labs (UAE), Medsol Diagnostics (UAE), Neuberg Diagnostics, and Alpha Medical Laboratory.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 GROWING PREVALENCE OF CHRONIC DISORDERS
- 4.2.2 INCREASED BURDEN OF TARGET DISEASES
4.3 RESTRAINTS
- 4.3.1 STRINGENT REGULATORY FRAMEWORK
- 4.3.2 HIGH COSTS OF ADVANCED TECHNOLOGIES
4.4 OPPORTUNITIES
- 4.4.1 INCREASING OUTSOURCING FROM HOSPITALS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GCC CLINICAL REFERENCE LABORATORIES MARKET
- 5.3.1 IMPACT ON CLINICAL TRIALS
- 5.3.2 IMPACT OF LABORATORY DEVELOPED TESTS (LDT) TO DIAGNOSE COVID-19
- 5.3.3 IMPACT ON TEST VOLUME, REVENUE, AND STAFFING

6 GCC CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE

6.1 OVERVIEW
6.2 HOSPITALS
6.3 STAND ALONE
6.4 CLINIC BASED

7 GCC CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 CLINICAL TRIALS
7.3 LABORATORY MEDICINE

8 GCC CLINICAL REFERENCE LABORATORY MARKET, BY COUNTRY

8.1 OVERVIEW
8.2 SAUDI ARABIA
8.3 UNITED ARAB EMIRATES
8.4 KUWAIT
8.5 QATAR
8.6 OMAN
8.7 BAHRAIN
8.8 IRAQ

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW
9.2 COMPETITIVE BENCHMARKING
9.3 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GCC CLINICAL REFERENCE LABORATORY MARKET
9.4 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.4.1 SERVICE LAUNCHES/PRODUCT APPROVALS
- 9.4.2 PARTNERSHIPS & AGREEMENTS

10 COMPANY PROFILES

10.1 UNILABS
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 SERVICES OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 QUEST DIAGNOSTICS INCORPORATED
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 SERVICES OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
10.3 SRL DIAGNOSTICS
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 SERVICES OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 SWOT ANALYSIS
- 10.3.6 KEY STRATEGIES
10.4 NEUBERG DIAGNOSTICS
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 SERVICES OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.4.6 KEY STRATEGIES
10.5 ALPHA MEDICAL LABORATORY
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 SERVICES OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 KEY STRATEGIES
10.6 MENALABS
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 SERVICES OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 KEY STRATEGIES
10.7 FREIBURG MEDICAL LABORATORY MIDDLE EAST (L.L.C)
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 SERVICES OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 KEY STRATEGIES
10.8 MEDSOL DIAGNOSTICS
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 SERVICES OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 KEY STRATEGIES
10.9 THUMBAY LABS
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 SERVICES OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
10.10 PURE LAB
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 SERVICES OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 SWOT ANALYSIS
- 10.10.6 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES
11.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 12
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 15
TABLE 3 GCC: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 29
TABLE 4 GCC: CLINICAL REFERENCE LABORATORY MARKET, FOR HOSPITALS, BY COUNTRY, 2018-2030 (USD MILLION) 29
TABLE 5 GCC: CLINICAL REFERENCE LABORATORY MARKET, FOR STAND ALONE, BY COUNTRY, 2018-2030 (USD MILLION) 30
TABLE 6 GCC: CLINICAL REFERENCE LABORATORY MARKET, FOR CLINIC BASED, BY COUNTRY, 2018-2030 (USD MILLION) 30
TABLE 7 GCC: CLINICAL REFERENCE LABORATORY MARKET, FOR APPLICATION, BY TYPE, 2018-2030 (USD MILLION) 32
TABLE 8 GCC: CLINICAL REFERENCE LABORATORY MARKET, FOR CLINICAL TRIALS, BY COUNTRY, 2018-2030 (USD MILLION) 32
TABLE 9 GCC: CLINICAL REFERENCE LABORATORY MARKET, FOR LABORATORY MEDICINE, BY COUNTRY, 2018-2030 (USD MILLION) 33
TABLE 10 GCC: CLINICAL REFERENCE LABORATORY MARKET, BY COUNTRY, 2018-2030(USD MILLION) 35
TABLE 11 GCC: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 36
TABLE 12 GCC: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 36
TABLE 13 SAUDI ARABIA: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 37
TABLE 14 SAUDI ARABIA: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 37
TABLE 15 UNITED ARAB EMIRATES: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 37
TABLE 16 UNITED ARAB EMIRATES: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 38
TABLE 17 KUWAIT: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 38
TABLE 18 KUWAIT: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 38
TABLE 19 QATAR: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 39
TABLE 20 QATAR: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 39
TABLE 21 OMAN: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 39
TABLE 22 OMAN: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 39
TABLE 23 BAHRAIN: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 40
TABLE 24 BAHRAIN: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 40
TABLE 25 IRAQ: CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2018-2030 (USD MILLION) 40
TABLE 26 IRAQ: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 40
TABLE 27 MAJOR PLAYERS IN THE GCC CLINICAL REFERENCE LABORATORY MARKET 41
TABLE 28 MOST ACTIVE PLAYER IN THE GCC CLINICAL REFERENCE LABORATORY MARKET 43
TABLE 29 SERVICE LAUNCHES/PRODUCT APPROVALS 43
TABLE 30 PARTNERSHIPS & AGREEMENTS 43
TABLE 31 UNILABS: SERVICES OFFERED 44
TABLE 32 UNILABS: KEY DEVELOPMENTS 45
TABLE 33 QUEST DIAGNOSTICS INCORPORATED: SERVICES OFFERED 47
TABLE 34 SRL DIAGNOSTICS: SERVICES OFFERED 50
TABLE 35 NEUBERG DIAGNOSTICS: SERVICES OFFERED 52
TABLE 36 NEUBERG DIAGNOSTICS: KEY DEVELOPMENTS 52
TABLE 37 ALPHA MEDICAL LABORATORY: SERVICES OFFERED 54
TABLE 38 MENALABS: SERVICES OFFERED 55
TABLE 39 FREIBURG MEDICAL LABORATORY MIDDLE EAST (L.L.C): SERVICES OFFERED 56
TABLE 40 MEDSOL DIAGNOSTICS: SERVICES OFFERED 58
TABLE 41 THUMBAY LABS: SERVICES OFFERED 59
TABLE 42 PURE LAB: SERVICES OFFERED 60

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 10
FIGURE 2 GULF COOPERATION COUNCIL (GCC) CLINICAL REFERENCE LABORATORY MARKET 11
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 17
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GCC CLINICAL REFERENCE LABORATORY MARKET 20
FIGURE 5 DRIVER IMPACT ANALYSIS 21
FIGURE 6 RESTRAINT IMPACT ANALYSIS 22
FIGURE 7 VALUE CHAIN ANALYSIS: GCC CLINICAL REFERENCE LABORATORY MARKET 23
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GCC CLINICAL REFERENCE LABORATORY MARKET 25
FIGURE 9 GCC CLINICAL REFERENCE LABORATORY MARKET, BY SERVICE, 2021 & 2030 (USD MILLION) 28
FIGURE 10 GCC: CLINICAL REFERENCE LABORATORY MARKET, BY APPLICATION, 2021 & 2030 (USD MILLION) 31
FIGURE 11 GCC CLINICAL REFERENCE LABORATORY MARKET, BY COUNTRY 2021 & 2030 (USD MILLION) 35
FIGURE 12 GCC: CLINICAL REFERENCE LABORATORY MARKET SHARE (%), BY COUNTRY 2021 36
FIGURE 13 BENCHMARKING OF MAJOR COMPETITORS 42
FIGURE 14 UNILABS: SWOT ANALYSIS 45
FIGURE 15 QUEST DIAGNOSTICS INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT 46
FIGURE 16 QUEST DIAGNOSTICS INCORPORATED: SWOT ANALYSIS 48
FIGURE 17 SRL DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT 49
FIGURE 18 SRL DIAGNOSTICS: SWOT ANALYSIS 51
FIGURE 19 NEUBERG DIAGNOSTICS: SWOT ANALYSIS 53
FIGURE 20 PURE LAB: SWOT ANALYSIS 61

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ